Literature DB >> 30794722

Obstructive Sleep Apnea Is Associated With Altered Glycemic Patterns in Pregnant Women With Obesity.

Sarah S Farabi1, Linda A Barbour2,3, Kristy Heiss2, Nicole M Hirsch2, Emily Dunn2, Teri L Hernandez2,4.   

Abstract

OBJECTIVE: Often unrecognized, obstructive sleep apnea (OSA) worsens over pregnancy and is associated with poorer perinatal outcomes. The association between OSA in late pregnancy and metabolic biomarkers remains poorly understood. We tested the hypothesis that OSA in pregnant women with obesity is positively correlated with 24-hour patterns of glycemia and IR despite controlling for diet.
DESIGN: Pregnant women (32 to 34 weeks' gestation; body mass index, 30 to 40 kg/m2) wore a continuous glucose monitor for 3 days. OSA was measured in-home by WatchPAT 200™ [apnea hypopnea index (AHI), oxygen desaturation index (ODI; number per hour)]. Fasting blood was collected followed by a 2-hour, 75-g, oral glucose tolerance test to measure IR. Association between AHI and 24-hour glucose area under the curve (AUC) was the powered outcome.
RESULTS: Of 18 women (29.4 ± 1.4 years of age [mean ± SEM]), 12 (67%) had an AHI ≥5 (mild OSA). AHI and ODI were correlated with 24-hour glucose AUC (r = 0.50 to 0.54; P ≤ 0.03) and mean 24-hour glucose (r = 0.55 to 0.59; P ≤ 0.02). AHI and ODI were correlated with estimated hepatic IR (r = 0.59 to 0.74; P < 0.01), fasting free fatty acids (fFFAs; r = 0.53 to 0.56; P < 0.05), and waking cortisol (r = 0.49 to 0.64; P < 0.05).
CONCLUSIONS: Mild OSA is common in pregnant women with obesity and correlated with increased glycemic profiles, fFFAs, and estimates of hepatic IR. OSA is a potentially treatable target to optimize maternal glycemia and metabolism, fetal fuel supply, and pregnancy outcomes.
Copyright © 2019 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30794722      PMCID: PMC6701202          DOI: 10.1210/jc.2019-00159

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  53 in total

1.  Parity and sleep patterns during and after pregnancy.

Authors:  K A Lee; M E Zaffke; G McEnany
Journal:  Obstet Gynecol       Date:  2000-01       Impact factor: 7.661

2.  Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test.

Authors:  Muhammad A Abdul-Ghani; Masafumi Matsuda; Bogdan Balas; Ralph A DeFronzo
Journal:  Diabetes Care       Date:  2007-01       Impact factor: 19.112

3.  Body-composition assessment in infancy: air-displacement plethysmography compared with a reference 4-compartment model.

Authors:  Kenneth J Ellis; Manjiang Yao; Roman J Shypailo; Alessandro Urlando; William W Wong; William C Heird
Journal:  Am J Clin Nutr       Date:  2007-01       Impact factor: 7.045

Review 4.  The developmental origins of insulin resistance.

Authors:  David J P Barker
Journal:  Horm Res       Date:  2006-01-20

5.  Changes in symptoms of sleep-disordered breathing during pregnancy.

Authors:  Grace W Pien; Daniel Fife; Allan I Pack; J Emeka Nkwuo; Richard J Schwab
Journal:  Sleep       Date:  2005-10       Impact factor: 5.849

Review 6.  Practice parameters for the indications for polysomnography and related procedures: an update for 2005.

Authors:  Clete A Kushida; Michael R Littner; Timothy Morgenthaler; Cathy A Alessi; Dennis Bailey; Jack Coleman; Leah Friedman; Max Hirshkowitz; Sheldon Kapen; Milton Kramer; Teofilo Lee-Chiong; Daniel L Loube; Judith Owens; Jeffrey P Pancer; Merrill Wise
Journal:  Sleep       Date:  2005-04       Impact factor: 5.849

7.  Cortisol increases gluconeogenesis in humans: its role in the metabolic syndrome.

Authors:  S Khani; J A Tayek
Journal:  Clin Sci (Lond)       Date:  2001-12       Impact factor: 6.124

8.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

Review 9.  The assessment of insulin resistance in man.

Authors:  T M Wallace; D R Matthews
Journal:  Diabet Med       Date:  2002-07       Impact factor: 4.359

10.  CPAP therapy of obstructive sleep apnea in type 2 diabetics improves glycemic control during sleep.

Authors:  Arthur Dawson; Susan L Abel; Richard T Loving; George Dailey; Farhad F Shadan; John W Cronin; Daniel F Kripke; Lawrence E Kline
Journal:  J Clin Sleep Med       Date:  2008-12-15       Impact factor: 4.062

View more
  6 in total

1.  Obstructive sleep apnea in pregnant women.

Authors:  Jennifer E Dominguez; Ashraf S Habib
Journal:  Int Anesthesiol Clin       Date:  2022-04-01

2.  Association between sleep disordered breathing in early pregnancy and glucose metabolism.

Authors:  Laura Sanapo; Margaret H Bublitz; Alice Bai; Niharika Mehta; Geralyn M Messerlian; Patrick Catalano; Ghada Bourjeily
Journal:  Sleep       Date:  2022-04-11       Impact factor: 6.313

3.  Sleep Duration, Sleep Timing, and Sleep Disordered Breathing-Associations With Obesity and Gestational Diabetes in Pregnancy.

Authors:  Francesca Facco
Journal:  Clin Obstet Gynecol       Date:  2021-03-01       Impact factor: 1.966

4.  Metabolic Culprits in Obese Pregnancies and Gestational Diabetes Mellitus: Big Babies, Big Twists, Big Picture : The 2018 Norbert Freinkel Award Lecture.

Authors:  Linda A Barbour
Journal:  Diabetes Care       Date:  2019-05       Impact factor: 19.112

5.  Associations Between Morning Salivary and Blood Cortisol Concentrations in Individuals With Obstructive Sleep Apnea Syndrome: A Meta-Analysis.

Authors:  Mohammad Moslem Imani; Masoud Sadeghi; Habibolah Khazaie; Arezoo Sanjabi; Serge Brand; Annette Brühl; Dena Sadeghi Bahmani
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-19       Impact factor: 5.555

6.  Innovations in Prospective Perinatal Research as a Result Of the COVID-19 Pandemic.

Authors:  Katherine Kissler; Rachel Blankstein Breman; Nicole Carlson; Ellen Tilden; Elise Erickson; Julia Phillippi
Journal:  J Midwifery Womens Health       Date:  2022-02-15       Impact factor: 2.891

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.